Methadone Patient Access to Collaborative Treatment
Key facts
- Who runs it
- University of Arizona
- Where
- Tucson, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 1,080 people, planned
- Started
- 5 Feb 2026
- Expected to end
- 30 Jun 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- MPACT
- Record updated
- 16 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Staff providing methadone treatment services at the enrolled opioid treatment programs
Who cannot take part
- Patients receiving methadone treatment at the enrolled opioid treatment programs
Where in United States
- University of Arizona College of NursingTucson, United StatesContact: Beth Meyerson, PhDTaking people
About the trial
What the trial wants to find out
The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose.
Read full original descriptionShow less
It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.
The 2 groups in the trial
- MPACT InterventionTreatment being tested
Enrolled clinic staff will be exposed to the MPACT intervention components over the trial period. This includes accredited training, clinic self assessment, reflective supervision for counseling/peer/case management staff, and wellness education with navigation to trauma symptoms assessment and resources including trauma treatment. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Treatment: MPACT
- Control for MPACTNo study treatment, for comparison
Enrolled clinic staff will not receive any portion of the intervention. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Methadone Patient Access to Collaborative Treatment (MPACT)
- Publications
- Record updated
- 16 July 2026